HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rummeliibacillus suwonensis: First Time Isolation from Human Feces by Culturomics.

Abstract
Gut microbiota is a complex ecosystem composed by trillions of microorganisms that are crucial for human health or disease status. Currently, there are two methodological options to explore its complexity: metagenomics and culturomics. Culturomics is an approach that uses multiple culture conditions (days of incubation, enrichment factors and growth temperature) and MALDI-TOF mass spectrometry for the identification of bacterial species and sequencing when this method fails. In this paper, we describe how Colturomic's protocol has allowed the first isolation in human sample of Rummeliibacillus suwonensis, a Gram positive, facultative anaerobe bacterium. The bacterium was isolated from feces of a 69 years old male with amyotrophic lateral sclerosis (ALS) recruited for a clinical trial assessing safety and efficacy of fecal microbiota transplantation in ALS. The first isolation of the microorganism dates back to 2013 from the soil of a South Korean mountain area. In this report, morphological description, biochemical characterization and antibiotic susceptibility tests were performed to outline the bacterial properties.
AuthorsGianluca Quaranta, Jessica Mandrioli, Stefano Bibbò, Alessandra Guarnaccia, Giovanni Fancello, Cecilia Simonini, Amedeo Amedei, Elena Niccolai, Giulia Nannini, Giovanni Cammarota, Maurizio Sanguinetti, Luca Masucci
JournalCurrent microbiology (Curr Microbiol) Vol. 79 Issue 7 Pg. 197 (May 20 2022) ISSN: 1432-0991 [Electronic] United States
PMID35595837 (Publication Type: Journal Article)
Copyright© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Chemical References
  • RNA, Ribosomal, 16S
Topics
  • Aged
  • Amyotrophic Lateral Sclerosis
  • Feces (microbiology)
  • Humans
  • Male
  • Planococcaceae (isolation & purification)
  • RNA, Ribosomal, 16S

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: